RecruitingNot ApplicableNCT07122219

Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons


Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Enrollment

548 participants

Start Date

Oct 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study is focused on improving the implementation of Prison Needle Exchange Programs (PNEPs) in Canadian federal prisons, with the goal of increasing the uptake of these programs among people who inject drugs in prison. The study is being conducted in nine federal prisons, including five women's prisons, where a higher proportion of incarcerated individuals report a history of injection drug use. This study aims to improve PNEP adoption and sustainability by identifying barriers and facilitators and implementing evidence-based strategies to enhance program engagement.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • All people incarcerated at a study site during the intervention period

Exclusion Criteria1

  • \- None (site level intervention)

Interventions

BEHAVIORALNIATx

The Network for the Improvement of Addiction Treatment (NIATx) model uses a bundle of implementation tools that include expert facilitation (coaching) and quality process improvement specifically for behavioural healthcare settings to improve access and retention in treatment.


Locations(9)

Edmonton Institution for Women

Edmonton, Alberta, Canada

Fraser Valley Institution for Women

Abbotsford, British Columbia, Canada

Mission Institution

Mission, British Columbia, Canada

Dorchester Medium

Dorchester, New Brunswick, Canada

Atlantic Institution

Smiths Crossing, New Brunswick, Canada

Nova Institution for Women

Truro, Nova Scotia, Canada

Joyceville Institution

Kingston, Ontario, Canada

Grand Valley Institution for Women

Kitchener, Ontario, Canada

Joliette Institution for Women

Joliette, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07122219


Related Trials